Cytek Biosciences said it plans to report its second-quarter 2026 financial results on Wednesday, August 5, 2026. The company stated that the update will be released after the market closes.
The announcement gives investors and market watchers a date to track as they look for the latest performance details from the Fremont, California-based biosciences company. Cytek Biosciences trades on Nasdaq under the ticker CTKB.
Quarterly earnings dates are closely watched because they provide insight into revenue trends, operating performance, and broader business momentum. For a life sciences and biosciences company, scheduled financial updates can also help frame investor expectations around commercial activity and overall market conditions.
By confirming its Q2 2026 reporting date in advance, Cytek Biosciences has added its name to the upcoming biotech earnings calendar for early August. More detailed financial information is expected when the company issues its full second-quarter report after the close of trading.
